PlainRecalls
FDA Drug Low Class III Terminated

Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20

Reported: March 19, 2014 Initiated: January 28, 2014 #D-1155-2014

Product Description

Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20

Reason for Recall

Failed Impurity/degradation Specification

Details

Units Affected
3,252 cartons
Distribution
US: Nationwide
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20. Recalled by Mylan Institutional, Inc. (d.b.a. UDL Laboratories). Units affected: 3,252 cartons.
Why was this product recalled?
Failed Impurity/degradation Specification
Which agency issued this recall?
This recall was issued by the FDA Drug on March 19, 2014. Severity: Low. Recall number: D-1155-2014.